ArticleERJ open research2025
Association between small airway dysfunction and cardiac conditions: a Swiss urban population cross-sectional study.
Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Small airways dysfunction: associated factors, clinical aspects and new perspectives.European respiratory review : an official journal of the European Respiratory Society · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Small airway dysfunction (SAD) may be an early sign of cardiopulmonary overload due to small airway mucosal thickening or be related to the oxidative stress characteristic of cardiovascular diseases. A high prevalence of SAD coexisting with chronic heart failure may be associated with an increase in all-cause mortality. We analysed the association between SAD and cardiac conditions in the PneumoLaus study. Methods: PneumoLaus is based on the Swiss general urban population cohort CoLaus|PsyCoLaus. SAD was defined by maximal mid-expiratory flow (MMEF) before bronchodilatation <65% predicted or MMEF<lower limit of normal (LLN) based on GLI-2012. Self-reported cardiac events were defined as new occurrence of any cardiac condition since baseline analysis (approximately 10 years before spirometry). Adjudicated cardiac conditions correspond to the confirmed diagnosis in the local medical record. We performed analyses with SAD criteria adjusted for age, sex, smoking duration, smoking status and body mass index (model 1). A second model was additionally adjusted for N-terminal pro-brain natriuretic peptide (NT-proBNP). Results: Among 3342 subjects that underwent spirometry, 473 (14.2%) reported a new cardiac condition. SAD defined as MMEF<65% predicted or MMEF<LLN was associated with self-reported cardiac conditions (OR 1.38, 95% CI 1.05-1.82 and OR 1.60, 95% CI 1.07-2.40) for model 1). This association persisted for SAD defined MMEF<LLN after adjustment for NT-proBNP. Adjudicated cardiac conditions were associated with SAD (defined as MMEF<LLN) in the unadjusted model and in model 1 (OR 1.85, 95% CI 1.05-3.27). Conclusions: SAD defined as MMEF<LLN was associated with self-reported and adjudicated cardiac conditions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.